Laddar...

Short-term sPECAM-Fc treatment ameliorates EAE while chronic use hastens onset of symptoms

The homotypic cell adhesion molecule PECAM-1 is a major participant in the migration of leukocytes across endothelium. We examined the ability of a chimeric soluble sPECAM-1 fused to human IgG-Fc to impair leukocyte entry through the blood-brain barrier and reduce CNS autoimmunity. sPECAM-Fc impaire...

Full beskrivning

Sparad:

Bibliografiska uppgifter
Huvudupphovsmän:	Reinke, Emily K., Lee, JangEun, Zozulya, Alla, Karman, Jozsef, Muller, William A., Sandor, Matyas, Fabry, Zsuzsanna
Materialtyp:	Artigo
Språk:	Inglês
Publicerad:	2007
Ämnen:	Article
Länkar:	https://ncbi.nlm.nih.gov/pmc/articles/PMC1950937/ https://ncbi.nlm.nih.gov/pubmed/17467062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jneuroim.2007.03.014
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!

Short-term sPECAM-Fc treatment ameliorates EAE while chronic use hastens onset of symptoms

Liknande verk